METZGER MICHAEL A (President and COO) sold 6.3% of their position (32.38K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $784.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/9/2026ACC: 0001193125-26-299803
Officer· President and COO
Since Feb 2019
+32.38K
Net shares
Net buyer
$784.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
64.75K acquired · 32.38K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+32.38K
Price / share
$6.38
Trade value
$206.55K
% of position
6.7%
7/8/2026
484.84K→517.22K
Common Stock
Direct
Shares
−32.38K
Price / share
$24.24
Trade value
$784.78K
% of position
6.3%
7/8/2026
517.22K→484.84K
Total
Net shares
+0.00
Net value
-$578.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | M · Option Exercise | +32.38K | $6.38 | $206.55K | 6.7% | 484.84K | 517.22K |
| Common Stock Direct | 7/8/2026 | S · Sale | −32.38K | $24.24 | $784.78K | 6.3% | 517.22K | 484.84K |
| Total | +0.00 | -$578.22K | ||||||
Derivative Transactions1
Stock Option (Right to buy)
Direct
Converts to
Common Stock
32.38K shares
Shares
+32.38K
Strike price
6.38
Held after
0.00
Exercisable
—
7/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock32.38K shares | 7/8/2026 | M · Option Exercise | +32.38K | 6.38 | — | 0.00 |